CBD Online Sales Regulations

Part
01
of one
Part
01

CBD Online Sales Regulations

Insights into the state of the FDA regarding CBD and CBD products include aspects of false claims regarding the benefits of CBD products, federally unapproved and misbranded drugs, and increased funding to develop CBD policies. Equally, insights into CBD online sales regulations show that a lot of concern and emphasis revolves around the labeling and marketing of CBD products.

I. State of the FDA Regarding CBD

False Claims

Unapproved and Misbranded Drugs

Budget for CBD Enforcement

II. CBD Online Sales Regulations

Regulation Around Selling CBD Online

Labeling of CBD Products

  • Research findings note that all CBD products must be labeled and marketed as per the Federal Food, Drug, and Cosmetic Act (FD&C Act). The labeling varies depending on whether the CBD product is a cosmetic, device, dietary supplement, or food.
  • As a seller of CBD products online, research findings suggest that labeling should provide robust information on the ingredients and dosing.
  • Likewise, the labeling should feature a URL or QR code leading to the testing results of the products and a Certificate of Analysis (CoA).

Shipping Carriers and Logistics

CBD Payment Gateways

Specifics with the State of California

Specifics with the State of New York

Research Methodology

Your research team searched for the most recent regulatory information about the FDA's position regarding CBD products. The reports explored include government databases, business websites, local news outlets, etc., and include Jsupra, Big Commerce, Digital Commerce 360, 3D Cart, etc. We also searched for the CBD regulatory frameworks for California and New York individually to be able to identify any specifics for each state. These sources featured information and insights into the CBD regulatory landscape in the nation. Overall, the insights provided focus more on the FDA's position regarding legalizing CBD products.
Sources
Sources